Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes. In recent years, CAR-T cell therapies have become ...

In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the ...

Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes ...

24 Although the benefit of CAR T-cell therapy for multiple myeloma continues to outweigh the risk, vigilant monitoring for T-cell lymphoma should be implemented. Supported by Johnson & Johnson and ...

Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies. Multiple myeloma starts in the plasma ...

Lynn Steele is a senior information specialist at the Leukemia & Lymphoma Society’s Information Resource Center in New York. She said combating multiple myeloma hinges on education and proactive ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...

Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer of the blood—also known as hematologic cancer. It affects cells called plasma cells, which are types of white blood ...

Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care This meta-analysis sheds more light on the beneficial impact of multiple melanoma ...

For 24 years, the Lymphoma, Leukemia & Myeloma Congress has stood as the premier educational conference dedicated to hematologic malignancies. Over 75 experts from around the globe gather in New ...